Could a cancer drug tame dangerous brain vessels?

NCT ID NCT06264531

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the drug bevacizumab, given through a vein, can improve symptoms like headaches, seizures, and thinking problems in people with brain arteriovenous malformations (AVMs) that are too large or risky for surgery or radiation. About 54 adults with moderate to severe symptoms will receive the drug to see if it reduces their disability. The goal is symptom control, not a cure, and participants may still need other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL AV MALFORMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HFAR

    RECRUITING

    Paris, Île-de-France Region, 75019, France